AUG 25, 2026 · REGULATORY LABEL UPDATE
FDA supplemental approval: Metoprolol Succinate (Labeling)
U.S. Food and Drug Administration
FDA supplemental approval for labeling changes to an existing metoprolol succinate extended-release tablet formulation; this is a regulatory action record, not a clinical evidence evaluation.
Reported
Approval date2026-08-25
Application numberANDA205541